David Burkhart | CEO
Inimmune Corp

Pre-Congress Workshops - Monday 30th March @ 10:00

Vaccine Technology Workshop

Topics:

·       Cutting-edge technologies shaping the future of vaccine development.  

·       Adjuvants

·       AI tools for Protein Design/Epitopes

Worlshop Chair: Dr David Burkhart, Chief Executive Officer, Inimmune

• 10am Chair’s Opening Remarks
• 10.10am Self-replicating RNA Platform Development
• 10.25am Designing the Next Generation of Vaccines: Harnessing Generative AI for In Silico Immunogen Discovery
• 10.40 Virus-Like Particle Display for Long-Lasting Vaccine Protection
  • Senior Representative, AdaptVac
• 10:55 Reserved
• 11:10 Reserved
• 11:25 Reserved
• 11:40 Title TBD
• 12:00 Panel: The Evolving Landscape of Novel Adjuvant Development – Navigating Safety, Access and Innovation
  • Safety as a priority and hurdle for the acceptance novel adjuvants
  • How can we further de-risk adjuvants?
  • Changing Models in licensing and access, how will non-exclusive licensing change the field?
  • Can innovation and adoption of new technologies overcome barriers in cost and access?